Pharmasat

---

General

Designation	35002 / 09028B
Launch date	19 May 2009
Country of origin	United States
Mission	Technology
Perigee/Apogee	436/473 km
Inclination	40.5°
Period	93.5 min
Launch vehicle	Minotaur #8

Will help scientists better understand how effectively drugs work in space.

It contains a controlled environment micro-laboratory packed with sensors and optical systems that can detect the growth, density and health of yeast cells and transmit that data to scientists for analysis on Earth. PharmaSat also will monitor the levels of pressure, temperature and acceleration the yeast and the satellite experience while circling Earth at 27,400 km/h. Scientists will study how the yeast responds during and after an antifungal treatment is administered at three distinct dosage levels to learn more about drug action in space, the satellite's primary goal.

The experiment lasts 96 hours.
Downlink at 437.465 MHz 1200 bps

---

End of life

Decay

14 Aug 2012

sat-index articles

Technical data

---

---

Specifications

Prime contractor	NASA
Platform
Mass at launch	4.5 kg
Dry mass
Dimension
Solar array
Stabilization
DC power
Design lifetime	6 months

---